Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Feb 15.
Published in final edited form as: Dev Biol. 2006 Oct 5;302(2):448–462. doi: 10.1016/j.ydbio.2006.09.051

lin‐35/Rb and the CoREST ortholog spr‐1 coordinately regulate vulval morphogenesis and gonad development in C. elegans

Aaron M Bender 1, Natalia V Kirienko 1, Sara K Olson 2, Jeffery D Esko 2, David S Fay 1,*
PMCID: PMC1933485  NIHMSID: NIHMS18646  PMID: 17070797

Abstract

Using a genetic screen to identify genes that carry out redundant functions during development with lin‐35/Rb, the C. elegans Retinoblastoma family ortholog, we have identified a mutation in spr‐1. spr‐1 encodes the C. elegans ortholog of human CoREST, a protein containing Myb‐like SANT and ELM2 domains, which functions as part of a transcriptional regulatory complex. CoREST recruits mediators of transcriptional repression, including histone deacetylase and demethylase, and interacts with the tumor suppression protein REST. spr‐1/CoREST was previously shown in C. elegans to suppress defects associated with loss of the presenilin sel‐12, which functions in the proteolytic processing of LIN‐12/Notch. Here we show that lin‐35 and spr‐1 coordinately regulate several developmental processes in C. elegans including the ingression of vulval cells as well as germline proliferation. We also show that loss of lin‐35 and spr‐1 hypersensitizes animals to a reduction in LIN‐12/Notch activity, leading to the generation of proximal germline tumors. This defect, which is observed in lin‐35; spr‐1; lin‐12(RNAi) and lin‐35; spr‐1; hop‐1(RNAi) triple mutants is likely due to a delay in the entry of germ cells into meiosis.

Keywords: lin‐35, retinoblastoma, spr‐1, CoREST, C. elegans, development

Introduction

The mammalian pocket proteins, which include the Retinoblastoma protein pRb and its paralogs, p107 and p130, are well‐established regulators of the cell cycle (reviewed by Kaelin, 1999; Harbour and Dean, 2000a; Classon and Dyson, 2001). In addition, numerous studies have implicated Rb family members in promoting cell differentiation as well as other processes related to development (reviewed by Harbour and Dean, 2000b; Morris and Dyson, 2001; Wikenhieser‐Brokamp, 2006). Although much of the evidence in support of a role for the pocket proteins in development has been obtained from tissue culture‐based systems, in vivo results have also provided several notable findings. For example, disruption of Rb family functions in the developing murine lung leads to increased expression of the neuroendocrine cell fate and a concomitant reduction in the specification of other epithelial cell types, suggesting that Rb family proteins control the development of specific cell lineages within the lung (Wikenheiser‐Brokamp, 2004). Furthermore, a role for Rb proteins in skin epithelial cell differentiation is supported by findings that ablation of p107 and p130 result in the impaired differentiation of keratinocytes (Ruiz et al., 2003). Interestingly, this study also revealed an apparent role for p107/p130 in the morphogenesis of epidermal hair follicles and incisors, which is independent of differentiation.

The extent to which these observed developmental defects are an indirect consequence of perturbations to the cell cycle is not entirely clear. Nevertheless, a number of recent in vivo findings support the idea that Rb family activities, including those connected to proliferation, differentiation, and apoptosis, may be functionally separable (de Bruin et al., 2003; MacPherson et al., 2003; Wu et al., 2003; Takahashi et al., 2004; Sage et al., 2005). This separation of functions is further supported at the mechanistic level by the recent finding that the RET finger protein (RFP) specifically inhibits gene transcriptional activation by pRb, but does not inhibit the repressive (cell cycle) functions of pRb (Krutzfeldt et al., 2005). Furthermore, microarray analyses suggest that the transcriptional targets of Rb family proteins as well as their well‐established DNA‐binding regulatory partners, the E2Fs, include many non‐cell cycle targets such as factors implicated in differentiation, signaling, and cell architecture (e.g., Muller et al., 2001; Markey et al., 2002; Polager et al., 2002; Black et al., 2003; Dimova et al., 2003; Balciunaite et al., 2005).

Further evidence in support of a role for the Rb and E2F family proteins in basic developmental functions includes studies from non‐mammalian systems. For example, in Drosophila, loss of the E2F co‐partner dDP results in ventralization of the embryo because of misexpression of the EGF‐like ligand Gurkin (Myster et al., 2000). Conversely in Xenopus, loss of E2F function leads to the elimination of posterior and ventral structures, whereas overexpression inhibits the formation of dorsal and anterior structures (Suzuki and Hemmati‐Brivanlou, 2000). A Role for E2F and Dp in establishing proper body axis patterning is also observed in C. elegans, where the loss of these orthologs leads to an early defect in the proper distribution of tissue‐specific transcriptional regulators (Page et al., 2001).

Studies on the C. elegans Rb family ortholog, lin‐35, have revealed both canonical cell cycle functions as well as many unexpected roles during development that appear in most cases to be unlinked to cell cycle regulation (reviewed by Fay, 2005). Interestingly, the majority of these functions cannot be detected through the analysis of lin‐35 single mutants. Rather these functions are revealed only when lin‐35 is inactivated in the appropriate mutant backgrounds, indicating that lin‐35 functions redundantly with other pathways to regulate both cell cycle and non‐cell cycle processes. This precedent for redundancy of lin‐35 functions was initiated by the discovery of a role for lin‐35 in inhibiting epidermal cells from inappropriately acquiring vulval cell fates (the synthetic multivulval [SynMuv] phenotype; Ferguson and Horvitz, 1989; Lu and Horvitz, 1998; reviewed by Fay, 2000), a function that it shares with the C. elegans E2F ortholog, efl‐1 (Ceol and Horvitz; 2001). Namely, animals that are mutant for lin‐35(or other members of the so‐called Class B group of SynMuv genes) and for genes of either the Class A (Ferguson and Horvitz, 1989) or Class C (Ceol and Horvitz, 2004) groups show a highly penetrant hyperinduction of vulval cells. The basis for this phenotype was recently shown to be the result of ectopic expression of LIN‐3, the EGF‐like ligand that is the primary inducer of vulval cell fates (Cui et al., 2006). Further studies looking for novel lin‐35 synthetic phenotypes have revealed roles for LIN‐35 in morphogenesis of the C. elegans pharynx (Fay et al., 2003, 2004), asymmetric cell divisions (Cui et al., 2004), execution of cell lineages within the somatic gonad (Bender et al., 2004), and larval growth (Cui et al., 2004; Cardoso et al., 2005; Chesney et al., 2006; Fay lab unpublished data), as well as a traditional role in cell cycle control (Boxem and van den Heuvel, 2001, Fay et al., 2002). lin‐35 also functions non‐redundantly to represses the expression of germline‐associated genes in somatic cells and lin‐35 mutants show hypersensitivity to RNAi (Wang et al., 2005). Finally, lin‐35 negatively regulates ribosome biogenesis at the level of rRNA expression (Voutev et al., 2006).

In this work, we describe a novel role for lin‐35 in the morphogenesis of the C. elegans vulva. Specifically, in double mutants of lin‐35 and the C. elegans CoREST transcriptional repressor ortholog, spr‐1, cells of the vulval epithelium fail to fully ingress, leading to an abnormally compressed vulval lumen at the L4 larval stage. Furthermore, this phenotype does not appear to result from primary defects in either cell cycle regulation or differentiation. We also show a role for lin‐35 and spr‐1 in promoting germline proliferation and in inhibiting the formation of proximal germline tumors. Interestingly, human CoREST is a key cofactor of the REST tumor suppressor gene (Andres et al., 1999; Westbrook et al., 2005). Based on these and other findings, we suggest that the non‐cell cycle functions of Rb family members may contribute to the tumor‐suppressing activities of these proteins.

Materials and Methods

C. elegans genetic methods and strains

All C. elegans strains were maintained according to standard methods (Stiernagle, 2005). All experiments were carried out at 20°C. Strains used in these studies include the following: N2 (wild type), CB4856, MH1461 [lin‐35(n745), kuEx119], NH2246 [ayIs4(egl‐17∷GFP)], WY301 [lin‐35(n745); egl‐17∷GFP], SU93 [jcis1 (ajm‐1∷GFP)], WY334 [spr‐1(fd6); lim‐7∷GFP], WY258 [spr‐1(fd6)], JK2868 [qIs56(lag‐2∷GFP)], MH1317 [kuIs29(egl‐13∷GFP)], GS1214 [sel‐12(ar171), unc‐1(e538)], WY329 [lin‐35(n745); lag‐2∷GFP], WY298 [lin‐35(n745); ajm‐1∷GFP], WY248 [lin‐35(n745); spr‐1(fd6); kuEx119], WY328 [lin‐35(n745); dpy‐11(e224), spr‐1(fd6), unc‐76(e911); kuEx119], WY294 [lin‐35(n745); spr‐1(fd6); lim‐7∷GFP; kuEx119], WY300 [lin‐35(n745); egl‐13∷GFP], WY295 [hop‐1(ar179); spr‐1(fd6); unc‐76(e911)], WY251 [lin‐35(n745); spr‐1(ar205); kuEx119], WY249 [lin‐35(n745); spr‐1(fd6); ajm‐1∷GFP; kuEx119], WY296 [lin‐35(n745); sel‐12(ar171), unc‐1(e538)], WY326 [lin‐35(n745); spr‐1(fd6); sel‐12(ar171), unc‐1(e538)], DG1575 [tnIs6(lim‐7∷GFP)], and WY299 [lin‐35(n745); lim‐7∷GFP].

spr‐1/slr‐10(fd6) genetic mapping

Based on the failure of spr‐1(fd6) to cosegregate with dpy‐11 and unc‐76, fd6 was assigned to the right arm of LGV. 59/79 Dpy non‐Unc and 14/55 Unc non‐Dpy recombinants segregating from lin‐35; dpy‐11, fd6, unc‐76/+ hermaphrodites retained fd6. The genetic region containing fd6 was further refined by SNP mapping according to standard methods (for details see Fay, 2006). fd6 was mapped to a 425‐kb region on LGV between the polymorphisms vm23b06.s1@42,a,42 on cosmid F40A3 and eam66g04.s1@467,t,51 on cosmid F21F8.

Transgene rescue

Rescue of fd6 was obtained through the injection of cosmids D1014 and F20D6 together with pRF4 into lin‐35; spr‐1; kuEx119(+) hermaphrodites (for details on methods see Evans, 2005). Rescue was inferred based on the appearance of roller animals that did not require kuEx119 for rapid growth or long‐term viability. In addition, transgenic rescue was also obtained with YAC Y97E10.

Complementation Test

spr‐1(ar205) males were crossed to lin‐35(n745); dpy11(e224), spr‐1(fd6), unc‐76(e911); kuEx119 hermaphrodites and Non‐Dpy Unc cross progeny containing the kuEx119 array were identified in the next generation, clonally transferred, and allowed to self fertilize. 60 non‐Dpy Unc kuEx119+ progeny were clonally transferred and subsequent generations were analyzed for their dependence on the array. 14/60 (23%; expect 25% based on the expected frequency of lin‐35 homozygous mutants) animals were found to require kuEx119 for normal health and viability. Of these 14 animals, nine gave rise to small broods containing Dpy Unc animals, indicating that the parental genotype was lin‐35(n745); dpy11(e224), spr‐1(fd6), unc‐76(e911)/spr‐1(ar205); kuEx119. Analysis of one of the nine balanced isolates revealed vulval morphology and gonad defects similar to those observed for lin‐35(n745); spr‐1(fd6) mutants (data not shown).

DAPI staining

Prior to staining, animals were fixed with ice‐cold methanol for 5 minutes in a glass depression slide. Animals were then washed several times with PBS (pH 7.4) containing 0.1% Tween 20. They were then incubated in 0.01 ng/µ1 DAPI for 1 hr at 4°C, washed several times with PBS, and placed on slides for microscopy.

Immunohistochemistry

Animals were collected in M9, placed on glass slides coated with poly‐L‐lysine, and freeze cracked (for details see Duerr, 2006). Slides were blocked with TBS containing 0.1% Tween 80, and animals were treated with 0.05 U/µ1 chondroitinase ABC for 1 hr at 37°C (Mizuguchi et al., 2003). The slides were then washed with TBS and incubated with the 1‐B‐5 chondroitin stub mAb (1:2000; Seikagaku) for 2–6 hr. After washing in TBS, slides were incubated with a Cy3‐conjugated donkey anti‐mouse secondary antibody (1:1000; Jackson ImmunoResearch) for 2 hr. After additional washing with TBS, slides were coated with mounting solution (Dabco) and visualized by fluorescence microscopy.

Western blotting

Crude extracts were prepared by sonicating worms in 50 mM NaAc (pH 6) with protease inhibitor cocktail (Sigma). The resulting extract (2 µg) was digested with 10 mU chondroitinase ABC (Seikagaku) for 3 hr at 37°C and analyzed by SDS‐PAGE, as described (Hwang et al., 2003). Chondroitin proteoglycan core proteins were detected by western blotting with the 1‐B‐5 chondroitin stub mAb (1:1000; Seikagaku) followed by a goat anti‐mouse secondary antibody (1:2000; BioRad). Blots were visualized with the WestPico Chemiluminescent Kit (Pierce).

RNAi by Feeding or Microinjection

RNAi feeding and microinjection experiments were carried out according to standard methods (Ahringer, 2005). For microinjection, all dsRNAs were injected into the syncytial germlines of adult hermaphrodites at a concentration of ∼1.0 µg/µ1. Injected animals were allowed to recover for 24 hr on NGM plates and were then transferred to fresh plates. F1 self‐progeny produced from 24–48 hr post‐injection were scored for the relevant phenotypes. Forward and reverse primer sequences used to amplify products for RNA were as follows: spr‐1, ATGGATTTGTATGACGATGATGGA and CTGCATATTTTCAGCTTTTTCTCCA; spr‐4, ATGTCGTCGGAACCAACTTCTT and TGACCTTGTGAACAATTAATTGTGTC; spr‐5, GTAAACTTCGAAGAGCACGGAG and CCGCCACTCCATTCTCC; hop‐1, GGACTAGTCGTATTAGCCAACAGCAT and CCGGCTCGAGAGCTGGAAATTTGTC; lin‐12, TCAGGAAAACGGGAACCATT and AATCGGCGTCTTTCCATCTT; efl‐1, ACATGGAGCTTCAAAAAGCG and CAATTCCTTCGAGAACATTCG. The T7 promoter sequence used was TAATACGACTCACTATAGGGA. All other primers were as previously described (Fay et al., 2002).

Results

lin‐35/Rb and spr‐1/slr‐10 are genetically redundant

Using a previously described genetic screen to identify proteins that perform overlapping functions with LIN‐35 (Fay et al., 2002), we isolated a single allele (fd6) defining a locus originally designated as slr‐10 (for synthetic with lin‐35/ Rb; hereafter referred to as spr‐1). Briefly, lin‐35(n745) homozygous animals that carry an extrachromosomal array (kuEx119) expressing wild‐type lin‐35 along with a GFP reporter were subjected to chemical mutagenesis. Following an F2 clonal screen, strains harboring synthetic mutations were identified based on the expression of visible phenotypes in animals that failed to inherit the array. Whereas both lin‐35 and spr‐1(fd6) single mutants were largely indistinguishable from wild type, lin‐35; spr‐1 double mutants were smaller and slower growing and had an abnormally clear or mottled appearance (Fig. 1A,Fig. 1B; data not shown). Also, as described below, lin‐35; spr‐1 mutants showed defects in vulval morphogenesis, somatic gonad development, and fertility.

Figure 1.

Figure 1.

A synthetic genetic interaction between lin‐35(n745) and spr‐1(fd6). DIC (A) and corresponding GFP fluorescence (B) images. White arrow indicates the position of the affected lin‐35; spr‐1 mutant that has failed to segregate the kuEx119 rescuing array. Scale in A, 100 µm for A,B.

fd6 defines a mutation in spr‐1, the C. elegans ortholog of human CoREST

fd6 was mapped to a small region on the right arm of LGV using classical genetic and SNP mapping techniques (see Materials and Methods; Fay, 2006). Two overlapping cosmids in the region, D1014 and F20D6, rescued the synthetic defects of lin‐35; spr‐1 animals completely. RNAi of genes contained on these cosmids in the lin‐35 mutant background led to the identification of a single clone (corresponding to D1014.8/spr‐1) that closely phenocopied the effects of the fd6 mutation (also see below). Sequence analysis of the spr‐1 coding region in the fd6 mutant background revealed a C to T transition at nucleotide position 1375 of the spr‐1 cDNA. This mutation produces a premature translational stop codon following amino acid 458 of the 558‐amino‐acid protein. Based on these data, along with the observed synthetic genetic interactions of other spr‐1 alleles with lin‐35 (see below) and the failure of a previously isolated allele of spr‐1 to complement fd6 (see Materials and Methods) we conclude that spr‐1 is the relevant locus defined by fd6.

spr‐1 encodes an ortholog of the human CoREST protein (Jarriault and Greenwald, 2002), which acts within a larger complex that includes the REST/NRSF tumor suppressor (Andres et al., 1999; Westbrook et al., 2005). The REST/CoREST complex is thought to represses the transcription of genes through the recruitment of histone deacetylases (Humphrey et al., 2001; You et al., 2001) and demethylases (Lee et al., 2005) to specific target sites. The fd6 mutation leads to a C‐terminal truncation of SPR‐1 just preceding the second of two conserved SANT domains. SANT domains are found in a number of chromatin remodeling enzymes and have been shown to function in chromatin binding through interactions with histone tails (Boyer et al., 2002).

Given that the original alleles of spr‐1 were identified on the basis of their ability to suppress the egg‐laying defective (Egl) phenotype of sel‐12 presenilin mutants (Jarriault and Greenwald, 2002), we tested spr‐1(fd6) for this capacity and found that it suppressed the Egl phenotype of 10/10 sel‐12(ar171) animals, indicating that spr‐1(fd6) can function in its canonical role as a sel‐12 suppressor. In contrast, 34/34 lin‐35; sel‐12 mutants were incapable of laying eggs, indicating that lin‐35 does not share this specific suppressive function with spr‐1.

lin‐35; Spr‐1 double mutants display defects in vulval morphogenesis

The C. elegans hermaphrodite egg‐laying and mating organ, the vulva, is derived from three epithelial precursor cells, which undergo a well‐defined series of cell divisions along with morphogenetic events that include migrations, cell shape changes, and cell fusions (Sternberg, 2005). During the mid‐L4‐stage, the vulva acquires a stereotypical “Christmas tree” morphology at which time it is comprised of seven vertically stacked multinucleate toroid (ring‐shaped) cells that contain a large central lumen (Fig. 2A; Fig. 3I). A number of mutations have been characterized that specifically affect the morphogenetic steps of vulval development including eight loci that result in a partially collapsed or “squashed” vulval lumen (The Sqv phenotype) at the L4 stage (Fig. 2E; Herman et al., 1999a; Sternberg, 2005). Although morphogenesis is severely defective, these sqv mutants display a wild‐type pattern of vulval cell divisions along with normal hallmarks of cell differentiation (Herman et al., 1999a).

Figure 2.

Figure 2.

lin‐35; spr‐1 mutants have defects in vulval morphogenesis. DIC images of mid‐L4‐stage wild‐type (A), lin‐35(n745); spr‐1(fd6) double mutant (B,C), lin‐35; spr‐1(RNAi) (D); sqv‐2(n2826) (E), and rib‐2(gk318) (F) hermaphrodite animals. Note the reduction in the area of the vulval lumen in the double mutants (B–D) and sqv‐2 (E) as compared with wild type (A). B and C show the range of Sqv phenotypes (most to least severe) displayed by the double mutants. Insets in A and B show vulval development in wild‐type and lin‐35; spr‐1 animals at the early L4 stage. Note that the vulval lumen is compressed in double mutants relative to wild type at this stage. Black arrowheads (D,E) demarcate the luminal processes formed by the vulval toroids. Note the increased compression of luminal processes in the double mutants (B–D) versus the wild‐type (A) and sqv‐2 (E) animals. rib‐2 mutants (F) do not display a Sqv phenotype but do show a low penetrance of vulval induction defects. The animal in F has an abnormal induction of the P8p.a lineage (white arrowhead) as well as an apparent under‐induction of the P7.p lineage (white bracket). Scale bar in A, 10 µm for A–E; in A inset, 10 µm for A,B insets; in F, 10 µm.

Figure 3.

Figure 3.

lin‐35; spr‐1 mutants undergo normal vulval cell divisions, differentiation patterns, and cell fusion events. DIC (A,C,E,G) and corresponding GFP fluorescence (B,D,F,H) images of wild‐type (E,F) and lin‐35; spr‐1(fd6) (A–D,G,H) developing vulvae. Panel I shows the vulval cell lineage during the L3 stage and a schematic of vulval morphology at the mid‐L4 stage in wild‐type animals. The fates of nuclei within the L3 lineage and the L4 vulva are indicated by color; wild‐type egl‐17∷GFP expression is indicated by the green line circumscribing cells in the lineage diagram (A,B) L3‐ and (C,D) L4‐stage lin‐35; spr‐1 mutants showing normal expression of egl‐17∷GPF in L3‐stage P6.p derivatives (A,B; white arrowheads) and in the L4‐stage N‐cells of P5.p and P7.p (C,D; white arrows; the T‐cells are not visible in this focal plane). (E–H) ajm‐1∷GFP, which marks the adherens junctions between the vulval toroids in wild‐type (E,F) and lin‐35; spr‐1 L4 animals (G,H). Black arrowheads indicate the GFP‐marked junctions between the vulval toroids. Although expression of this marker is fainter in the lin‐35; spr‐1 mutants (most likely due to the silencing effect of lin‐35 mutations on transgenic arrays; Hsieh et al., 1999), seven toroids can reproducibly be identified in vulvae from both animals. Scale bar in A, 10 µm, for A–H.

We found that most lin‐35; spr‐1 double mutants exhibited a phenotype that was similar to that previously reported for the sqv mutants. Namely, the vulval lumen of lin‐35; spr‐1 mutants was substantially compressed at the mid‐L4 stage relative to wild type or the large majority of lin‐35 and spr‐1 single mutants (Fig. 2B,Fig. 2C; Table 1; data not shown). This defect in vulval morphogenesis was also observed in lin‐35; spr‐1(RNAi) and spr‐1; lin‐35(RNAi) animals (Fig. 2D; Table 1) including (in the latter case) multiple independently isolated alleles of spr‐1 (Table 1). The Sqv‐like phenotype was also manifest in double mutants at time points preceding the mid‐L4 stage (Fig. 2A,Fig. 2B insets; Fig. 3C,Fig. 4I), similar to previously described sqv mutants (Herman et al., 1999a). This indicates that underlying defect in lin‐35; spr‐1 double mutants somehow impinges on the ability of the vulval cells to undergo normal ingression.

Table 1.

Vulval and germline phenotypes

Genotype     Sqv (%)     Oocytes/arm
N2     0 (n=31)     7.0 (±1.4) (range, 4–10) (n=52)
lin‐35(n745)     11 (n=27)     6.7 (±1.7) (range, 4–12) (n=27)
spr‐1(fd6)     3 (n=30)     7.8 (±1.9) (range, 5–11) (n=28)
spr‐1(ar205)     0 (n=26)     ND
spr‐1(ar200)     7 (n=28)     ND
lin‐35; spr‐1(fd6)     63 (n=88)     2.9 (±1.2) (range, 1–5) (n=28)
lin‐35; spr‐1(ar205)     53 (n=30)     2.6 (±0.9) (range, 1–4) (n=38)
             
spr‐1(fd6); lin‐35(RNAi)     48 (n=21)     ND
spr‐1(ar200); lin‐35(RNAi)     26 (n=19)     ND
spr‐1(ar205); lin‐35(RNAi)     27 (n=22)     ND
lin‐35; spr‐1(RNAi)     64 (n=36)     4.5 (±1.7) (n=36)
             
spr‐4(RNAi)     8 (n=35)     ND
lin‐35; spr‐4(RNAi)     53 (n=15)     ND
spr‐5(RNAi)     10 (n=20)     ND
lin‐35; spr‐5(RNAi)     67 (n=24)     ND
             
lin‐35; spr‐1(fd6); lin‐12(RNAi)     54 (n=26)     2.5 (±1.0) (range, 1–5) (n=29)
lin‐35; spr‐1(fd6); hop‐1(RNAi)     77 (n=22)     2.9 (±1.0) (range, 1–5) (n=30)
lin‐12(RNAi)     7 (n=27)     6.4 (±0.9) (range, 5–8) (n=27)
hop‐1(RNAi)     0 (n=21)     6.5 (±1.0) (range, 5–9) (n=21)

All RNAi experiments were carried out using injection methods. n values for oocyte counts were based on individual gonad arms.

Figure 4.

Figure 4.

lin‐35; spr‐1 mutants show defects in gonad morphology and somatic cell positioning. DIC images of wild‐type (A) and lin‐35; spr‐1(fd6) mutant (B) adult gonads. Note reduction in the size and number of oocytes in the double mutant. DIC (C,E,G,I) and corresponding GFP fluorescence (D,F,H,J) images of wild‐type (C,D,G,H) and lin‐35; spr‐1 (E,F,I,J) adult (C–F) or L4‐stage (G–J) animals. Panels C–F show gonads in animals that express the lim‐7∷GFP marker for sheath cells. Note the reduction in expression of the marker in the proximal half of the gonad arm in the lin‐35; spr‐1 mutant. Panels G–J show animals that express the cog‐2∷GFP marker for uterine π cells. Whereas the majority of wild‐type animals contained six lateral π cells per side (G,H), lin‐35; spr‐1 mutants typically showed an asymmetry in π cell distribution (I,J). This difference was highly significant according to a two‐sample t‐test (p≪ 0.001). (K) Distribution of proximal sheath cell nuclei in wild‐type, lin‐35, spr‐1, and lin‐35; spr‐1 animals. Dots represent experimental data; curves represent corresponding best‐fit normal‐distribution density functions. Wild‐type animals contained an average of 4.6 (n=24; range, 4–6) sheath cell nuclei within the proximal half of their gonad arms, whereas lin‐35; spr‐1 double mutants contained an average of 3.0 (n=29; range, 1–5) nuclei in this region. This difference was very significant according to a two‐sample t‐test (p≪ 0.001). Scale bar in A, 10 µm, for A–F; in G, 10 µm, for G–J.

Our analysis of vulval development in the double mutants based on the cell lineage did not reveal any obvious defects. Cells divisions occurred in their normal characteristic planes and with the appropriate relative timing to consistently produce 22 nuclei (data not shown). To more thoroughly assess vulval cell fate specification and differentiation in lin‐35; spr‐1 animals, we examined expression of the egl‐17∷GFP marker in the double mutants (gift of M. Stern). In wild‐type animals, egl‐17∷GFP is initially expressed in dividing vulval cells that are derivatives of P6.p. Following the terminal divisions, this expression shifts to the N and T lineages of P5.p and P7.p (Fig. 3I; Burdine et al., 1998). We found that wild‐type and lin‐35; spr‐1 animals showed identical patterns of egl‐17∷GFP expression, further indicating that vulval cells in the double mutants adopt their correct fates (Fig. 3AFig. 3D; data not shown). We also assessed the ability of vulval cells in lin‐35; spr‐1 animals to form multinucleate toroid‐shaped cells using the adherens junction marker ajm‐1∷GFP (gift of J. Hardin; Mohler et al., 1998). Wild‐type L4 animals contain seven toroids and thus six easily identifiable (GFP‐marked) foci located at the junction of each toroid (n=14; Fig. 3E,Fig. 3F). Similarly, lin‐35; spr‐1 double mutants contained an average of 5.9 ± 0.3 (n=10) GFP‐positive foci at this same stage (Fig. 3G,Fig. 3H). Taken together, these data strongly indicate that there is a lack of vulval cell lineage, differentiation, and fusion defects in lin‐35; spr‐1 double mutants and imply that the observed morphogenesis defects are due to other causes.

Our finding that vulval cell patterning and cell‐fate assignments appear to be normal in the double mutants is similar to previous findings with other sqv mutants (Herman et al., 1999a). We did note several qualitative differences, however, between the vulval morphologies of lin‐35; spr‐1 mutants and previously described sqv mutants. Specifically, compression of the luminal processes that delineate the toroid rings was typically more severe in lin‐35; spr‐1 animals (Fig. 2BFig. 2E). In addition, the vulval phenotype of double mutants displayed more variability than was seen for most sqv mutants (Fig. 2BFig. 2D; Fig. 3G; data not shown).

The synthetic Sqv phenotype of lin‐35; spr‐1 mutants does not result from gross defects in chondroitin biosynthesis or localization

Investigation of the eight previously characterized sqv genes has placed them in a coherent pathway involved in the biosynthesis of the glycosaminoglycans (GAGs) heparan sulfate and chondroitin (Herman and Horvitz, 1999b; Bulik et al., 2000; Hwang and Horvitz, 2002a,b; Hwang et al., 2003a). Furthermore, the identification of a glycosyltransferase (SQV‐5) that is specific for the biosynthesis of chondroitin has implicated chondroitin deficiencies as the underlying cause of the Sqv phenotype (Hwang et al., 2003b). In support of this, we found that rib‐2, which encodes an enzyme required specifically for the initiation and elongation of heparan sulfate (Kitagawa et al., 2001; Morio et al., 2003), was not required for the formation of a normal vulval lumen (n=40; Fig. 2F). Interestingly, we did observe a low frequency (14%, n=29) of vulval induction defects in rib‐2(gk318) mutants (Fig. 2F), suggesting that as in other systems, heparan sulfate may modulate paracrine signaling through the conjugation of peptide growth factors in C. elegans (Powell et al., 2004; Iwamoto and Mekada, 2006).

In order to test whether chondroitin biosynthesis is impaired in lin‐35; spr‐1 double mutants, lysates were prepared from synchronized wild‐type, lin‐35, and spr‐1 single‐mutant animals as well as lin‐35 mutants subjected to spr‐1 RNAi feeding. Following treatment with chondroitinase ABC, samples were separated by electrophoresis, transferred to a membrane, and probed with a mAb directed against the remaining stub oligosaccharides on chondroitin proteoglycans (Olson et al., 2006). Although there may have been a slight reduction in the total levels of chondroitin proteoglycans in lin‐35 single mutants versus wild type, the levels in lin‐35; spr‐1(RNAi) double mutants were equivalent to those in lin‐35 single mutants (based on two independent experiments; Fig. 5A and data not shown). These results indicate that lin‐35 and spr‐1 do not function redundantly to promote chondroitin biosynthesis, and that in contrast to the sqv mutants, the Sqv phenotype in double mutants is not correlated with a strong reduction in chondroitin biosynthesis.

Figure 5.

Figure 5.

Analysis of chondroitin expression in wild type and mutants. (A) Western blot indicating levels of chondroitin in wild‐type, lin‐35 single‐mutant and lin‐35; spr‐1(RNAi) animals. The multiple bands indicate several species of chondroitin proteoglyan core proteins. DIC (B,D,F) and fluorescence (C,E,G) images of wild‐type (B,C), lin‐35; spr‐1 (D,E) and sqv‐2(n2826) mutants early‐ or mid‐L4 vulvae stained with a mAb specific for the chondroitin stub epitope. The majority of both wild‐type and lin‐35; spr‐1 L4 animals showed similar vulval‐specific staining patterns that were never observed in sqv‐2(n2826) mutants, which cannot synthesize chondroitin. Also see Results. Scale bar in B, 10 µm, for B–G.

To determine whether lin‐35; spr‐1 mutants might exhibit localized changes in chondroitin levels, we carried out immunocytochemistry to assay chondroitin expression in whole animals. Although this staining procedure showed some inherent variability within controlled sample sets, we did observe clear vulval staining in the majority of L4‐stage wild‐type (24/27) and lin‐35; spr‐1 (17/24) double mutants. Furthermore, staining levels of the two genotypes were observed to be roughly equivalent (Fig. 5BFig. 5E; data not shown). As a control, no staining was observed in sqv‐2(n2826) mutants, which are defective at chondroitin biosynthesis (Fig. 5F,Fig. 5G). Based on these findings, along with several qualitative differences in the outward appearance of the vulval phenotype (see above), we conclude that unlike previously identified sqv mutants, the synthetic Sqv phenotype of lin‐35; spr‐1 double mutants is not attributable to either substantive global or local alterations in chondroitin biosynthesis or distribution. This conclusion is further supported by our observation that simultaneous loss of lin‐35, spr‐1 and either sqv‐2 or sqv‐7 leads to vulval phenotypes that are qualitatively additive and also typically more severe than either lin‐35; spr‐1 or the sqv mutants alone (data not shown).

lin‐35; spr‐1 double mutants display fertility and germline defects

lin‐35; spr‐1 animals that failed to inherit the rescuing array displayed a substantially reduced brood size compared with wild type and single mutants (Table 2). This effect on brood size was greatly exacerbated in subsequent generations of double‐mutant animals derived from parents that lacked the kuEx119 extrachromosomal array (Table 2). Similar fertility defects were also observed in lin‐35; spr‐1(ar205) mutant animals, further demonstrating that other alleles of spr‐1 can synergize with lin‐35 loss of function (LOF; Table 2). Consistent with the observed fertility defects, DIC and DAPI staining revealed that double mutants have substantially smaller gonad arms relative to those of wild type or single mutants and contain fewer germ cells (the Glp phenotype) at all stages and fewer oocytes in adults (Fig. 4A,Fig. 4B; Fig. 6AFig. 6D; Table 1; data not shown). The gonadal and germline defects observed in the double mutants were robustly rescued by expression of either lin‐35 or spr‐1 via a repetitive extrachromosomal array (Fig. 1; data not shown). Given that such arrays are typically silenced in the germline, this suggests that the underlying defects may be due to a somatic requirement for these genes.

Table 2.

Brood size analysis

Genotype     Brood size       Sterility (%)
N2a     264 (±18) (n=50)       0 (n=50)
lin‐35(n745)a     98 (±43) (n=10)       3 (n=100)
spr‐1(fd6)     215 (±41) (n=20)       0 (n=20)
lin‐35; spr‐1(fd6)     20 (±18) (n=43)       10 (n=48)
lin‐35; spr‐1(fd6) (Mat‐)b     5 (±3) (n=10)       86 (n=70)
lin‐35; spr‐1(ar205)     19 (±13) (n=15)       4 (n=25)
lin‐35; spr‐1(ar205) (Mat‐)b     12 (±13) (n=13)       57 (n=30)
a

Brood size results taken from Fay et al., 2002.

b

Mat‐ indicates that the double‐mutant animals were derived from parents that lacked the kuEx119 extrachromosomal array, which may contribute maternal lin‐35.

Figure 6.

Figure 6.

Germline defects in lin‐35; spr‐1 and lin‐35; spr‐1; hop‐1 mutants. DIC (A,C) and corresponding DAPI fluorescence (B,D) images of wild‐type (A,B) and lin‐35; spr‐1(fd6) (C,D) adults. Note the reduction in germ cell numbers and oocytes as well as the extended pachytene meiotic region present in lin‐35; spr‐1 double mutants versus wild type (B,D). Proximal germline tumor (E) and residual bodies from spermatocytes (white arrowheads; F) in the gonads of lin‐35; spr‐1; hop‐1(RNAi) adult animals. Inset in F shows the morphology of a late‐stage L4/early adult animal containing spermatocytes, residual bodies, and spermatids for reference. DIC (G) and corresponding DAPI fluorescence (H) images of lin‐35; spr‐1; hop‐1(RNAi) animals. The tumor nuclei are densely packed and have a morphology characteristic of mitotically dividing cells. DAPI staining of (I) lin‐35; lin‐12(RNAi) and (J) lin‐35; spr‐1; lin‐12(RNAi) mid‐L4‐stage animals. Note the absence of transition and pachytene meiotic nuclei in the triple mutants Scale Bar in A, 10 µm, for A–J, in F inset, 10 µm.

The impaired fertility and diminutive gonads of lin‐35; spr‐1 double mutants is similar to previous findings for xnp‐1 lin‐35 double mutants (Bender and Fay; 2004). In the case of xnp‐1 lin‐35 animals, this defect could be attributed to an absence or significant reduction in the number of gonadal sheath cells, which are required for proper expansion of the germline stem cell population during larval development (McCarter et al., 1997; Killian and Hubbard, 2005). To examine the status of sheath cells in double mutants, we used the lim‐7∷GFP reporter, which is expressed consistently in the cytoplasm (and more variably in the nuclei) of eight of the ten sheath cell pairs (1–4) that encapsulate each gonad arm (Hall et al., 1999). We observed an average of 7.0 sheath cell nuclei (n=24; range, 6–8) per gonad arm in wild‐type animals (Fig. 4C,Fig. 4D). Similarly, lin‐35; spr‐1 double mutants had 6.5 sheath cell nuclei (n=29; range, 5–8) per gonad arm (Fig. 4E,Fig. 4F). From this we conclude that there is not a gross deficiency in the number of sheath cell nuclei in lin‐35; spr‐1 double mutants, although it is possible that these cells are nevertheless defective in their ability to promote germ cell proliferation. We note that although sheath cell number did not differ appreciably from that of wild type, we did observe a strong shift in the positioning of the sheath cells in lin‐35; spr‐1 animals toward the distal half of the gonad arm (Fig. 4E,Fig. 4F,Fig. 4K), a phenomenon that could be a secondary consequence of germline proliferation defects.

We also examined π‐cells of the ventral uterine lineage using the cog‐2∷GFP reporter (Hanna‐Rose and Han, 1999). We observed an average of 12 π‐cells in both wild‐type (n=24; range, 11–13) and lin‐35; spr‐1(RNAi) (n=24; range, 10–13) animals, indicating that π‐cells are also correctly specified in the double mutant. However, whereas 79% of wild‐type animals consistently had 6 π‐cells per lateral side at the mid‐L4 stage (n=24), only 25% (n=24) of lin‐35; spr‐1(RNAi) animals displayed an equal lateral distribution of these cells (Fig. 4GFig. 4J). In contrast, single mutants did not display π‐cell distribution defects (data not shown). These data suggest that although lin‐35 and spr‐1 are not required for cell‐type specification or differentiation per se, they may redundantly regulate subtle aspects of somatic gonad development such as organization, morphology, and function.

spr‐1 is synthetic with other Class B SynMuv genes

To determine whether the vulval and germline defects observed in lin‐35; spr‐1 mutants could be phenocopied by reducing the activities of other SynMuv genes (see Introduction), we tested several class B as well as one class A and one class C genes for genetic interactions with spr‐1 (Table 3; reviewed by Sternberg, 2005; Fay and Han, 2000). Of the class B genes tested, lin‐37 along with the E2F ortholog efl‐1 produced strong and moderate effects, respectively. In contrast, lin‐36 failed to shown an interaction, indicating that some, but not all, class B genes function with lin‐35 in its redundant role with spr‐1. Furthermore, the class A (lin‐15a) and class C (trr‐1) genes showed only weak or no effects, similar to previous slr mutants studied (Fay et al, 2002; Fay et al., 2003,2004; Bender et al., 2004).

Table 3.

spr‐1(fd6) interactions with Synthetic Multivulval (SynMuv) genes.

RNAia       SynMuv class       Sqv (%)
Vectorb             0 (n=22)
H2Oc             3 (n=30)
lin‐35       B       31 (n=54)
lin‐36       B       0 (n=13)
lin‐37       B       45 (n=20)
efl‐1       B       17 (n=42)d
lin‐15a       A       9 (n=43)e
trr‐1f       C       0 (n=18)
a

RNAi was carried out using standard feeding methods (Ahringer, 2006) with the exception of efl‐1, which was carried out using injection methods. As a control, all of the clones tested were observed to induce a highly penetrant multivulval phenotype in the appropriate genetic backgrounds (data not shown).

b

pPD129.36 was used as the control empty vector for the feeding experiments.

c

Injection of H2O is the control for efl‐1 RNAi.

d

p‐value based on proportion tests (relative to H2O injection) = 2.0 ×10−4.

e

p‐value based on proportion tests (relative to H2O injection) = 0.04.

f

trr‐1(RNAi) caused a low‐percentage multivulval phenotype in the spr‐1 mutant background (data not shown).

We also note that inactivation of several other components of the C. elegans CoREST complex in the lin‐35 mutant background led to similar synthetic defects as those observed with spr‐1. These included spr‐4, which encodes a C2H2‐type finger protein (Lakowski et al., 2003), and spr‐5, a putative histone demethylase (Table 1; Eimer et al., 2002; Jarriault and Greenwald, 2002). Taken together, these results support the model that both lin‐35 and spr‐1 carry out their redundant functions within the context of multisubunit transcriptional regulatory complexes.

The lin‐35; spr‐1 phenotype is not likely to be attributable to LIN‐12/Notch hypersignaling

As described above, spr‐1 was originally identified for its ability to suppress the Egl phenotype of sel‐12 mutants (Jarriault and Greenwald, 2002), and sel‐12 is itself a suppressor of gain‐of‐function (GOF) mutations in lin‐12/Notch (Levitan and Greenwald, 1995). sel‐12 encodes a presenilin‐like protease that is required for the (site 3) cleavage and signaling capacity of Notch receptors (Greenwald, 2005). A second presenilin gene in C. elegans, hop‐1, functions redundantly with sel‐12, as hop‐1; sel‐12 double mutants are synthetically lethal (Li and Greenwald, 1997; Westlund et al., 1999). It has been suggested that the C. elegans CoREST complex may act directly on the hop‐1 locus to mediate transcriptional repression, as hop‐1 mRNA is upregulated in several CoREST complex mutant backgrounds (Eimer et al., 2002; Lakowski et al., 2003). Thus, it was possible that the synthetic phenotype of lin‐35; spr‐1 mutants is due, at least in part, to an increase in hop‐1 abundance and, by extension, LIN‐12/Notch signaling activity.

To test this model, we inactivated lin‐12 and hop‐1 in lin‐35; spr‐1 mutants using RNAi injection methods and scored for suppression of the synthetic Sqv and germline defects. The efficacy of these RNAi treatments was first verified by showing that lin‐12(RNAi) induced a highly penetrant Egl phenotype in wild‐type animals and that hop‐1(RNAi) led to synthetic lethality in the sel‐12 mutant background (data not shown;Sundaram and Greenwald, 1993; Li and Greenwald, 1997; Westlund et al., 1999). We found that neither treatment was capable of mitigating either the vulval or germline defects of the double mutants (Table 1). These results indicate that increased levels of HOP‐1 activity or LIN‐12 signaling are unlikely to be a cause of the double mutant phenotype. Consistent with this, other phenotypes associated with lin‐12 hypermorphic alleles, such as the ectopic induction of secondary vulval cell fates or loss of the gonadal anchor cell, were not observed in the double mutants (data not shown; Sternberg, 2005; Greenwald, 2005).

lin‐35, spr‐1 double‐mutant germlines are hypersensitive to reductions in lin‐12/Notch signaling

Although we failed to detect any suppressive effects of hop‐1 or lin‐12 RNAi on the vulval and germline defects of lin‐35; spr‐1 mutants, we did observe proximal germline tumors (the Pro phenotype) in 21 and 24% of individual gonad arms from lin‐35; spr‐1; hop‐1(RNAi) and lin‐35; spr‐1; lin‐12(RNAi) animals, respectively (referred to as triple mutants; Fig. 6E,Fig. 6G,Fig. 6H; Table 4). In contrast, lin‐35; spr‐1 double mutants as well as all other possible binary combinations of double mutants showed little or no expression of the Pro phenotype (Table 4). In addition, adult triple mutants often harbored residual bodies (from spermatocytes) in the proximal gonad region (Fig. 6F; Table 4). Residual bodies are a relatively short‐lived bi‐product of spermatogenesis and are typically absent in adults. Residual bodies were not observed in wild‐type adults, although they were observed at somewhat elevated frequencies in most double‐mutant combinations (Table 4).

Table 4.

Proximal germline proliferation (Pro) phenotypes

Genotype     Pro (%)a     Adults containing residual bodies (%)a
N2     0 (n=69)     6 (n=69)
lin‐35; spr‐1     2 (n=98)     11 (n=37)
hop‐1; spr‐1b     2 (n=126)     13 (n=31)
lin‐35; hop‐1(RNAi)     0 (n=58)     ND
lin‐35; spr‐1; hop‐1(RNAi)     21 (n=154)     44 (n=52)
             
lin‐35; sel‐12c     0 (n=40)     ND
lin‐35; sel‐12; spr‐1b,c     10 (n=61)     23 (n=61)
             
spr‐1; lin‐12(RNAi)e     0 (n=37)     11 (n=37)
lin‐35; lin‐12(RNAi)     4 (n=72)     4 (n=72)
lin‐35; spr‐1; lin‐12(RNAi)     24 (n=45)     62 (n=45)

All RNAi experiments were carried out using injection methods.

The fd6 allele of spr‐1 was used in all experiments.

a

Phenotypes were scored per gonad arm.

b

spr‐1(fd6) was linked to unc‐76(e911).

c

sel‐12(ar171) was linked to unc‐1(e538).

d

Actual strain was of genotype lin‐35; spr‐1; lin‐12(RNAi); kuEx119, which is rescued for the lin‐35 mutant defect.

The Pro phenotype is defined by abnormal cell divisions in the proximal region of the adult germline and is discernible as a mass of densely packed mitotic nuclei (Seydoux et al., 1990). This phenotype has been reported to arise by several distinct mechanisms including the dedifferentiation of developing (meiotic) spermatocytes into mitotically dividing cells (Subramaniam and Seydoux, 2003). In addition, careful analysis has shown the Pro phenotype to result indirectly from delays in the initial entry of proximal germ cells into meiosis (Pepper et al., 2003a; Killian and Hubbard, 2004, 2005). This delay can occur when the germline fails to proliferate sufficiently during larval development, such that the proximal germ cells remain under the mitosis‐promoting influence of the distal tip cell (via LAG‐2/Delta and GLP‐1/Notch signaling). This failure of the proximal germ cells to enter meiosis in a timely manner renders them susceptible to the mitosis‐promoting influence of the proximal sheath cells (Sh2‐5) that come into contact with the proximal germ cells during the mid‐L4 stage (Killian and Hubbard, 2005). Therefore, it is critical that germ cells enter meiosis prior to the birth of Sh2‐5, as subtle delays can lead to maintenance of a mitotic state and the generation of proximal tumors.

Several features of the meiotic entry delay mechanism were consistent with our observations of the triple mutants including a highly penetrant reduction in the proliferation capacity of the triple‐mutant germline. In addition, it has been shown that lin‐12 LOF results in delays in the timing of initial meiosis (Killian and Hubbard, 2005; Killian thesis, 2004) and that lin‐12 null mutants form proximal tumors and contain adult‐stage spermatocytes (Seydoux et al., 1990). In contrast, puf‐8(RNAi), which leads to highly penetrant proximal tumors via the spermatocyte dedifferentiation pathway, does not typically affect germline proliferation (Subramaniam and Seydoux, 2003). Furthermore, other phenotypes associated with puf‐8 LOF that occur as a consequence of meiotic defects were not observed in the double or triple mutants examined (data not shown; Subramaniam and Seydoux, 2003). Finally, the presence of residual bodies in triple mutant adults is consistent with a delay in the initiation of meiosis and in the subsequent induction of spermatogenesis.

To test for delays in the timing of initial meiosis in lin‐35; spr‐1; hop‐1(RNAi) and lin‐35; spr‐1; lin‐12(RNAi) triple‐mutant animals, we examined gonads by DAPI staining at the mid‐L4 stage, at which time a substantial proportion of wild‐type germ cells have normally entered meiosis (Hubbard and Greenstein, 2005). We found that in contrast to wild type as well as all possible double‐mutant combinations, triple mutants were specifically defective in meiotic entry (Table 5; Fig. 6I,Fig. 6J). These results correlate precisely with the expression of the Pro phenotype in the triple‐mutant, but not the double‐mutant, combinations (Table 4). Furthermore, these findings are highly consistent with previous studies linking delays in the timing of initial meiosis to the Pro phenotype (Pepper et al., 2003a; Killian and Hubbard, 2004; Killian and Hubbard, 2005). In particular, we note that lin‐35; lin‐12(RNAi) animals showed neither a pronounced meiotic entry delay nor a Pro phenotype, indicating that our level of lin‐12 inactivation was not sufficient on its own to induce obvious germline defects (Fig. 6I and Table 4); lin‐35; lin‐12(RNAi) animals did display the Egl phenotype, and 2/15 animals assayed contained two anchor cells (data not shown), consistent with a partial loss of lin‐12 function. Thus, lin‐35; spr‐1 mutants are highly sensitized to the effects of lin‐12 LOF on germline development. This result is reminiscent of previous findings showing that ablation of sheath cell pair 1 (Sh1), which leads to both a meiotic entry delay and germline underproliferation, sensitizes the animals to slight increases in GLP‐1/Notch activity, effectively resulting in a synthetic Pro phenotype.

Table 5.

Germline meiotic progression at the mid‐L4 stage

Genotype     Mitotic     Transition     Pachytene     n
N2     148±24     19±4     56±24     8
lin‐35; hop‐1(RNAi)     95±13     12±5     38±5     9
lin‐35; lin‐12(RNAi)     85±15     10±2     46±7     8
spr‐1; hop‐1(RNAi)a     93±11     25±5     38±6     10
spr‐1; lin‐12(RNAi)a     85±16     20±6     29±5     10
lin‐35; spr‐1     37±6     8±2     31±9     7
lin‐35; spr‐1; hop‐1(RNAi)     48±11     5±3b     11±10c     8
lin‐35; spr‐1; lin‐12(RNAi)     47±14     5±3d     16±13e     17

All RNAi experiments were carried out using injection methods. The fd6 allele of spr‐1 was used in all experiments. n indicates the number of gonad arms scored.

a

Scored animals contained the lin‐35(n745) mutation together with the lin‐35 rescuing array kuEx119.

b

3/8 gonad arms contained no transition‐stage nuclei. p‐value based on t test (relative to lin‐35; spr‐1) was < 0.01.

c

2/8 gonad arms contained no pachtytene‐stage nuclei. p‐value based on t test (relative to lin‐35; spr‐1) was ≪ 0.01.

d

8/17 gonad arms contained no transition‐stage nuclei. p‐value based on t test (relative to lin‐35; spr‐1) was ≪ 0.001.

e

8/17 gonad arms contained no pachytene‐stage nuclei. p‐value based on t test (relative to lin‐35; spr‐1) was ≪ 0.001.

Discussion

lin‐35/Rb and spr‐1/CoREST function redundantly during C. elegans development

We found that lin‐35 and spr‐1 redundantly control several aspects of somatic gonad and germline development. With respect to development of the vulva, our results demonstrate that lin‐35 and spr‐1 coordinately promote the normal ingression of vulval cells during the late L3 and L4 stages of development (Table 1; Figure 2,Figure 3). This phenotype is superficially similar to that of the sqv mutants, which act in a common pathway to promote chondroitin biosynthesis (reviewed by Bulik and Robbins, 2002). Although our findings do not support a model whereby chondroitin biosynthesis or localization is grossly altered in the double mutants (as is the case for the sqv mutants; Fig. 5), we cannot rule out the possibility that very subtle differences in chondroitin levels, processing, or conjugation to specific proteoglycan core components may play a role in the observed phenotype. Nevertheless, clear qualitative differences in the vulval morphologies of lin‐35; spr‐1 and the sqv mutants, along with the normal localization pattern of chondroitin observed in lin‐35; spr‐1 vulvae, argue against chondroitin‐related defects as being causative to the lin‐35; spr‐1 vulval phenotype.

We have also shown a role for lin‐35 and spr‐1 in germline proliferation and in the prevention of proximal germline tumors when LIN‐12/Notch signaling is compromised (Fig. 4,Fig. 6; Table 4,Table 5). Based on previous published studies (Killian and Hubbard, 2004,2005), we hypothesize that lin‐35 and spr‐1 contribute to the Pro phenotype through their roles in redundantly promoting germline proliferation (also see results). At present, our data does not indicate whether lin‐35 and spr‐1 promote germline proliferation autonomously or via the soma. Nevertheless, our studies strongly imply that the Pro phenotype of lin‐35; spr‐1; lin‐12(RNAi) and lin‐35; spr‐1; hop‐1(RNAi) triple mutants results from a delay in the timing of initial meiosis, consistent with previous studies (Pepper et al., 2003a; Killian and Hubbard, 2004; Killian and Hubbard, 2005). Curiously, loss of lin‐35 can also suppress the Pro phenotype of pro‐1 mutants by partially alleviating defects due to rRNA processing deficiencies (Voutev, et al., 2006). Thus, depending on developmental context and strain background, lin‐35 can act as either a suppressor or enhancer of proximal germline proliferation.

Redundancy among transcriptional regulators

Genetic redundancy, which implies an overlap in the functions of the encoded protein products, can occur through a myriad of mechanisms. For example, the synthetic hyperproliferative phenotype of lin‐35; fzr‐1 mutants results from a failure to repress the expression of G1 cyclins adequately (Fay et al., 2002). In this case, LIN‐35, acting as a transcriptional repressor, and FZR‐1, functioning as a component of the APC ubiquitin ligase complex, act at distinct points (transcriptional versus post‐translational) to control the protein levels of a mutual target. In contrast, as described in the introduction, LIN‐35 acting together with other SynMuv genes specifically represses lin‐3 at the level of transcription (Cui et al., 2006). Although the precise molecular functions of the Class A SynMuv genes are not known, these proteins localize to the nucleus and are likely to function as transcriptional regulators (Clark et al., 1994; Huang et al., 1994; Davison et al., 2005).

It is of interest to note that of the seven genes identified through our lin‐35 synthetic screen, four function as regulators of transcription (spr‐1; Bender et al., 2004; Cui et al., 2004; D.S.F. and J.D. McEnerney, unpublished data). Furthermore, mutations in gon‐14 are also synthetic with lin‐35, and GON‐14 contains a putative THAP DNA‐binding domain and localizes to the nucleus (Chesney et al., 2006). Thus, although transcriptional regulators account for less than 8% of encoded genes in C. elegans, they are strongly over‐represented among the group of known lin‐35 synthetic interactors. This observation is consistent with findings from a large‐scale synthetic screen in S. cerevisiae showing that genes encoding proteins with similar molecular functions (based on gene ontologies) are more likely to display genetic redundancy than are genes with dissimilar functions (Tong et al., 2004). Thus, a useful (though imperfect) predictor for functional redundancy in metazoa may be based on proteins that have similar molecular functions.

The role of pocket in tumor suppression

In this study, we have identified an additional role for lin‐35 in epithelial cell movement and ingression. Although we have yet to identify the underlying basis for this phenotype, straightforward possibilities include reduced or altered adhesion properties of the migrating vulval cells or defects in cell polarity that may lead to a diminution of cell movements. Together with our previous observations demonstrating a role for lin‐35 in controlling cell orientation and polarity during pharyngeal morphogenesis (Fay et al., 2003, 2004), these results suggest that lin‐35 controls several properties of cells that are known to be specifically derailed in mammalian metastatic cancers (reviewed by Christofori, 2006).

It is possible that similar functions for Rb family members also exist in mammals but have not been observed to date because of functional overlap between the Rb family members, or as is the case in C. elegans, because of genetic redundancy with independent pathways. Additional tumor‐suppressive functions may further explain why the Rb pathway is functionally inactivated in most or all human cancers (Sherr, 1996, 2004; Sherr and McCormick, 2002). Furthermore, a role for Rb in tumor suppression beyond cell cycle control is supported by the finding that loss of cell cycle control alone is not sufficient to predispose cells of the retina to form retinoblastomas (Nakayama et al., 1996; Levin et al., 2001; Deyer et al., 2001; Cunningham et al., 2002; reviewed by Bremner et al., 2004). We speculate that genes identified as showing synthetic interactions with lin‐35 may function in certain contexts as tumor suppressors in mammals. Our identification of spr‐1/CoREST, which functions in mammals as the copartner of the REST tumor suppressor protein, lends credence to this possibility. Another gene identified by our screen, fzr‐1/Cdh1, is strongly downregulated in murine lymphoma cells, and transgenic expression of murine fzr‐1 in these cells reverts their tumorous growth properties (Wang et al., 2000). Finally, the recent finding that LIN‐35 redundantly represses expression of the EGF family member LIN‐3 suggests that suppression of paracrine growth factor signaling may be another mechanism by which Rb family members inhibit cell growth and thereby function to prevent tumorogenesis (Cui et al., 2006). Thus, the analysis of lin‐35 functions during development may provide valuable insights into novel mechanisms of tumor suppression by the Rb family.

Acknowledgements

We are especially indebted to Jane Hubbard for helpful suggestions and comments and to Amy Fluet for input on the manuscript. We thank Michael Stern, Jeff Hardin, Bill Mohler, Wendy Hanna‐Rose, and David Greenstein for reagents. This work was supported by a Research Scholar Grant from the American Cancer Society (RSG‐03‐035‐01‐DDC) and GM066868 (to D.S.F) and G33063 (to J.D.E) from the National Institutes of Health.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Ahringer J. Reverse Genetics, WormBook. The. C. elegans. Research Community, Ed. 2005 http://www.wormbook.org.
  2. Andres ME, Burger C, Peral‐Rubio MJ, Battaglioli E, Anderson ME, Grimes J, Dallman J, Ballas N, Mandel G. CoREST: a functional corepressor required for regulation of neural‐specific gene expression. Proc Natl Acad Sci U S A. 1999;96:9873–9878. doi: 10.1073/pnas.96.17.9873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balciunaite E, Spektor A, Lents NH, Cam H, Te Riele H, Scime A, Rudnicki MA, Young R, Dynlacht BD. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol. 2005;25:8166–8178. doi: 10.1128/MCB.25.18.8166-8178.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bender AM, Wells O, Fay DS. lin‐35/Rb and xnp‐1/ATR‐X function redundantly to control somatic gonad development in C. elegans. Dev Biol. 2004;273:335–349. doi: 10.1016/j.ydbio.2004.06.009. [DOI] [PubMed] [Google Scholar]
  5. Berry LW, Westlund B, Schedl T. Germ‐line tumor formation caused by activation of glp‐1 a Caenorhabditis elegans member of the Notch family of receptors. Development. 1997;124:925–936. doi: 10.1242/dev.124.4.925. [DOI] [PubMed] [Google Scholar]
  6. Black EP, Huang E, Dressman H, Rempel R, Laakso N, Asa SL, Ishida S, West M, Nevins JR. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 2003;63:3716–3723. [PubMed] [Google Scholar]
  7. Boxem M, van den Heuvel S. lin‐35 Rb and cki‐1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans. Development. 2001;128:4349–4359. doi: 10.1242/dev.128.21.4349. [DOI] [PubMed] [Google Scholar]
  8. Boyer LA, Langer MR, Crowley KA, Tan S, Denu JM, Peterson CL. Essential role for the SANT domain in the functioning of multiple chromatin remodeling enzymes. Mol Cell. 2002;10:935–942. doi: 10.1016/s1097-2765(02)00634-2. [DOI] [PubMed] [Google Scholar]
  9. Bremner R, Chen D, Pacal M, Livne‐Bar I, Agochiya M. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models. Dev Neurosci. 2004;26:417–434. doi: 10.1159/000082284. [DOI] [PubMed] [Google Scholar]
  10. Bulik DA, Robbins PW. The Caenorhabditis elegans sqv genes and functions of proteoglycans in development. Biochim Biophys Acta. 2002;1573:247–257. doi: 10.1016/s0304-4165(02)00391-4. [DOI] [PubMed] [Google Scholar]
  11. Bulik DA, Wei G, Toyoda H, Kinoshita‐Toyoda A, Waldrip WR, Esko JD, Robbins PW, Selleck SB. sqv‐3 ‐7 and ‐8 a set of genes affecting morphogenesis in Caenorhabditis elegans encode enzymes required for glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A. 2000;97:10838–10843. doi: 10.1073/pnas.97.20.10838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burdine RD, Branda CS, Stern MJ. EGL‐17(FGF) expression coordinates the attraction of the migrating sex myoblasts with vulval induction in C. elegans. Development. 1998;125:1083–1093. doi: 10.1242/dev.125.6.1083. [DOI] [PubMed] [Google Scholar]
  13. Cardoso C, Couillault C, Mignon‐Ravix C, Millet A, Ewbank JJ, Fontes M, Pujol N. XNP‐1/ATR‐X acts with RB HP1 and the NuRD complex during larval development in C. elegans. Dev Biol. 2005;278:49–59. doi: 10.1016/j.ydbio.2004.10.014. [DOI] [PubMed] [Google Scholar]
  14. Ceol CJ, Horvitz HR. dpl‐1 DP and efl‐1 E2F act with lin‐35 Rb to antagonize Ras signaling in C. elegans vulval development. Mol Cell. 2001;7:461–473. doi: 10.1016/s1097-2765(01)00194-0. [DOI] [PubMed] [Google Scholar]
  15. Ceol CJ, Horvitz HR. A new class of C. elegans synMuv genes implicates a Tip60/NuA4‐like HAT complex as a negative regulator of Ras signaling. Dev Cell. 2004;6:563–576. doi: 10.1016/s1534-5807(04)00065-6. [DOI] [PubMed] [Google Scholar]
  16. Chesney MA, Kidd AR, 3rd, Kimble J. gon‐14 functions with class B and class C synthetic multivulva genes to control larval growth in Caenorhabditis elegans. Genetics. 2006;172:915–928. doi: 10.1534/genetics.105.048751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Christofori G. New signals from the invasive front. Nature. 2006;441:444–450. doi: 10.1038/nature04872. [DOI] [PubMed] [Google Scholar]
  18. Clark SG, Lu X, Horvitz HR. The Caenorhabditis elegans locus lin‐15 a negative regulator of a tyrosine kinase signaling pathway encodes two different proteins. Genetics. 1994;137:987–997. doi: 10.1093/genetics/137.4.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Classon M, Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp Cell Res. 2001;264:135–147. doi: 10.1006/excr.2000.5135. [DOI] [PubMed] [Google Scholar]
  20. Cui M, Chen J, Myers TR, Hwang BJ, Sternberg PW, Greenwald I, Han M. SynMuv genes redundantly inhibit lin‐3/EGF expression to prevent inappropriate vulval induction in C. elegans. Dev Cell. 2006;10:667–672. doi: 10.1016/j.devcel.2006.04.001. [DOI] [PubMed] [Google Scholar]
  21. Cui M, Fay DS, Han M. lin‐35/Rb cooperates with the SWI/SNF complex to control Caenorhabditis elegans larval development. Genetics. 2004;167:1177–1185. doi: 10.1534/genetics.103.024554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Cunningham JJ, Levine EM, Zindy F, Goloubeva O, Roussel MF, Smeyne RJ. The cyclin‐dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Mol Cell Neurosci. 2002;19:359–374. doi: 10.1006/mcne.2001.1090. [DOI] [PubMed] [Google Scholar]
  23. Davison EM, Harrison MM, Walhout AJ, Vidal M, Horvitz HR. lin‐8 which antagonizes Caenorhabditis elegans Ras‐mediated vulval induction encodes a novel nuclear protein that interacts with the LIN‐35 Rb protein. Genetics. 2005;171:1017–1031. doi: 10.1534/genetics.104.034173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. de Bruin A, Wu L, Saavedra HI, Wilson P, Yang Y, Rosol TJ, Weinstein M, Robinson ML, Leone G. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb‐deficient mice. Proc Natl Acad Sci U S A. 2003;100:6546–6551. doi: 10.1073/pnas.1031853100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dimova DK, Stevaux O, Frolov MV, Dyson NJ. Cell cycle‐dependent and cell cycle‐independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev. 2003;17:2308–2320. doi: 10.1101/gad.1116703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Duerr JS. Immunohistochemistry WormBook. The. C. elegans. Research Community Ed. 2005 http://www.wormbook.org.
  27. Dyer MA, Cepko CL. The p57Kip2 cyclin kinase inhibitor is expressed by a restricted set of amacrine cells in the rodent retina. J Comp Neurol. 2001;429:601–614. [PubMed] [Google Scholar]
  28. Eimer S, Lakowski B, Donhauser R, Baumeister R. Loss of spr‐5 bypasses the requirement for the C.elegans presenilin sel‐12 by derepressing hop‐1. Embo J. 2002;21:5787–5796. doi: 10.1093/emboj/cdf561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Evans TC. Transformation and Microinjection WormBook. The. C. elegans. Research Community Ed. 2005 http://www.wormbook.org.
  30. Fay DS. The cell cycle and development: lessons from C. elegans. Semin Cell Dev Biol. 2005;16:397–406. doi: 10.1016/j.semcdb.2005.02.002. [DOI] [PubMed] [Google Scholar]
  31. Fay DS. Genetic Mapping and Manipulation WormBook. The. C. elegans. Research Community Ed. 2006 http://www.wormbook.org.
  32. Fay DS, Han M. The synthetic multivulval genes of C. elegans: functional redundancy Ras‐antagonism and cell fate determination. Genesis. 2000;26:279–284. doi: 10.1002/(sici)1526-968x(200004)26:4<279::aid-gene100>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  33. Fay DS, Keenan S, Han M. fzr‐1 and lin‐35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen. Genes Dev. 2002;16:503–517. doi: 10.1101/gad.952302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fay DS, Large E, Han M, Darland M. lin‐35/Rb and ubc‐18 an E2 ubiquitin‐conjugating enzyme function redundantly to control pharyngeal morphogenesis in C. elegans. Development. 2003;130:3319–3330. doi: 10.1242/dev.00561. [DOI] [PubMed] [Google Scholar]
  35. Fay DS, Qiu X, Large E, Smith CP, Mango S, Johanson BL. The coordinate regulation of pharyngeal development in C. elegans by lin‐35/Rb pha‐1 and ubc‐18. Dev Biol. 2004;271:11–25. doi: 10.1016/j.ydbio.2004.03.022. [DOI] [PubMed] [Google Scholar]
  36. Ferguson EL, Horvitz HR. The multivulva phenotype of certain Caenorhabditis elegans mutants results from defects in two functionally redundant pathways. Genetics. 1989;123:109–121. doi: 10.1093/genetics/123.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Greenwald I. LIN‐12/Notch signaling in C. elegans WormBook. The. C. elegans. Research Community Ed. 2005 http://www.wormbook.org.
  38. Hall DH, Winfrey VP, Blaeuer G, Hoffman LH, Furuta T, Rose KL, Hobert O, Greenstein D. Ultrastructural features of the adult hermaphrodite gonad of Caenorhabditis elegans: relations between the germ line and soma. Dev Biol. 1999;212:101–123. doi: 10.1006/dbio.1999.9356. [DOI] [PubMed] [Google Scholar]
  39. Hanna‐Rose W, Han M. COG‐2 a sox domain protein necessary for establishing a functional vulval‐uterine connection in Caenorhabditis elegans. Development. 1999;126:169–179. doi: 10.1242/dev.126.1.169. [DOI] [PubMed] [Google Scholar]
  40. Harbour JW, Dean DC. Rb function in cell‐cycle regulation and apoptosis. Nat Cell Biol. 2000a;2:E65–E67. doi: 10.1038/35008695. [DOI] [PubMed] [Google Scholar]
  41. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000b;14:2393–2409. doi: 10.1101/gad.813200. [DOI] [PubMed] [Google Scholar]
  42. Herman T, Hartwieg E, Horvitz HR. sqv mutants of Caenorhabditis elegans are defective in vulval epithelial invagination. Proc Natl Acad Sci U S A. 1999;96:968–973. doi: 10.1073/pnas.96.3.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Herman T, Horvitz HR. Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway. Proc Natl Acad Sci U S A. 1999;96:974–979. doi: 10.1073/pnas.96.3.974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hsieh J, Liu J, Kostas SA, Chang C, Sternberg PW, Fire A. The RING finger/B‐box factor TAM‐1 and a retinoblastoma‐like protein LIN‐35 modulate context‐dependent gene silencing in Caenorhabditis elegans. Genes Dev. 1999;13:2958–2970. doi: 10.1101/gad.13.22.2958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Huang LS, Tzou P, Sternberg PW. The lin‐15 locus encodes two negative regulators of Caenorhabditis elegans vulval development. Mol Biol Cell. 1994;5:395–411. doi: 10.1091/mbc.5.4.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hubbard EJ, Greenstein D. Introduction to the Germline WormBook. The. C. elegans. Research Community, Ed. 2005 http://www.wormbook.org.
  47. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y, Howard BH. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta‐L1. J Biol Chem. 2001;276:6817–6824. doi: 10.1074/jbc.M007372200. [DOI] [PubMed] [Google Scholar]
  48. Hwang HY, Horvitz HR. The Caenorhabditis elegans vulval morphogenesis gene sqv‐4 encodes a UDP‐glucose dehydrogenase that is temporally and spatially regulated. Proc Natl Acad Sci U S A. 2000a;99:14224–14229. doi: 10.1073/pnas.172522499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hwang HY, Horvitz HR. The SQV‐1 UDP‐glucuronic acid decarboxylase and the SQV‐7 nucleotide‐sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development. Proc Natl Acad Sci U S A. 2000b;99:14218–14223. doi: 10.1073/pnas.172522199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Hwang HY, Olson SK, Brown JR, Esko JD, Horvitz HR. The Caenorhabditis elegans genes sqv‐2 and sqv‐6 which are required for vulval morphogenesis encode glycosaminoglycan galactosyltransferase II and xylosyltransferase. J Biol Chem. 2003a;278:11735–11738. doi: 10.1074/jbc.C200518200. [DOI] [PubMed] [Google Scholar]
  51. Hwang HY, Olson SK, Esko JD, Horvitz HR. Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature. 2003b;423:439–443. doi: 10.1038/nature01634. [DOI] [PubMed] [Google Scholar]
  52. Iwamoto R, Mekada E. ErbB and HB‐EGF signaling in heart development and function. Cell Struct Funct. 2006;31:1–14. doi: 10.1247/csf.31.1. [DOI] [PubMed] [Google Scholar]
  53. Jarriault S, Greenwald I. Suppressors of the egg‐laying defective phenotype of sel‐12 presenilin mutants implicate the CoREST corepressor complex in LIN‐12/Notch signaling in C. elegans. Genes Dev. 2002;16:2713–2728. doi: 10.1101/gad.1022402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kaelin WG., Jr Functions of the retinoblastoma protein. Bioessays. 1999;21:950–958. doi: 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  55. Killian DJ, Hubbard EJ. C. elegans pro‐1 activity is required for soma/germline interactions that influence proliferation and differentiation in the germ line. Development. 2004;131:1267–1278. doi: 10.1242/dev.01002. [DOI] [PubMed] [Google Scholar]
  56. Killian DJ, Hubbard EJ. Caenorhabditis elegans germline patterning requires coordinated development of the somatic gonadal sheath and the germ line. Dev Biol. 2005;279:322–335. doi: 10.1016/j.ydbio.2004.12.021. [DOI] [PubMed] [Google Scholar]
  57. Kimble J, Crittenden SL. Germline proliferation and its control WormBook. The. C. elegans. Research Community Ed. 2005 doi: 10.1895/wormbook.1.13.1. http://www.wormbook.org. [DOI] [PMC free article] [PubMed]
  58. Kitagawa H, Egusa N, Tamura JI, Kusche‐Gullberg M, Lindahl U, Sugahara K. rib‐2 a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes encodes a novel alpha1,4‐N‐acetylglucosaminyltransferase involved in the biosynthetic initiation and elongation of heparan sulfate. J Biol Chem. 2001;276:4834–4838. doi: 10.1074/jbc.C000835200. [DOI] [PubMed] [Google Scholar]
  59. Krutzfeldt M, Ellis M, Weekes DB, Bull JJ, Eilers M, Vivanco MD, Sellers WR, Mittnacht S. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell. 2005;18:213–224. doi: 10.1016/j.molcel.2005.03.009. [DOI] [PubMed] [Google Scholar]
  60. Lakowski B, Eimer S, Gobel C, Bottcher A, Wagler B, Baumeister R. Two suppressors of sel‐12 encode C2H2 zinc‐finger proteins that regulate presenilin transcription in Caenorhabditis elegans. Development. 2003;130:2117–2128. doi: 10.1242/dev.00429. [DOI] [PubMed] [Google Scholar]
  61. Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature. 2005;437:432–435. doi: 10.1038/nature04021. [DOI] [PubMed] [Google Scholar]
  62. Levine EM, Close J, Fero M, Ostrovsky A, Reh TA. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev Biol. 2000;219:299–314. doi: 10.1006/dbio.2000.9622. [DOI] [PubMed] [Google Scholar]
  63. Levitan D, Greenwald I. Facilitation of lin‐12‐mediated signalling by sel‐12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature. 1995;377:351–354. doi: 10.1038/377351a0. [DOI] [PubMed] [Google Scholar]
  64. Li X, Greenwald I. HOP‐1 a Caenorhabditis elegans presenilin appears to be functionally redundant with SEL‐12 presenilin and to facilitate LIN‐12 and GLP‐1 signaling. Proc Natl Acad Sci U S A. 1997;94:12204–12209. doi: 10.1073/pnas.94.22.12204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lu X, Horvitz HR. lin‐35 and lin‐53 two genes that antagonize a C. elegans Ras pathway encode proteins similar to Rb and its binding protein RbAp48. Cell. 1998;95:981–991. doi: 10.1016/s0092-8674(00)81722-5. [DOI] [PubMed] [Google Scholar]
  66. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol. 2003;23:1044–1053. doi: 10.1128/MCB.23.3.1044-1053.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, Knudsen ES. Unbiased analysis of RB‐mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 2002;62:6587–6597. [PubMed] [Google Scholar]
  68. McCarter J, Bartlett B, Dang T, Schedl T. Soma‐germ cell interactions in Caenorhabditis elegans: multiple events of hermaphrodite germline development require the somatic sheath and spermathecal lineages. Dev Biol. 1997;181:121–143. doi: 10.1006/dbio.1996.8429. [DOI] [PubMed] [Google Scholar]
  69. Mizuguchi S, Uyama T, Kitagawa H, Nomura KH, Dejima K, Gengyo‐Ando K, Mitani S, Sugahara K, Nomura K. Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature. 2003;423:443–448. doi: 10.1038/nature01635. [DOI] [PubMed] [Google Scholar]
  70. Mohler WA, Simske JS, Williams‐Masson EM, Hardin JD, White JG. Dynamics and ultrastructure of developmental cell fusions in the Caenorhabditis elegans hypodermis. Curr Biol. 1998;8:1087–1090. doi: 10.1016/s0960-9822(98)70447-6. [DOI] [PubMed] [Google Scholar]
  71. Morio H, Honda Y, Toyoda H, Nakajima M, Kurosawa H, Shirasawa T. EXT gene family member rib‐2 is essential for embryonic development and heparan sulfate biosynthesis in Caenorhabditis elegans. Biochem Biophys Res Commun. 2003;301:317–323. doi: 10.1016/s0006-291x(02)03031-0. [DOI] [PubMed] [Google Scholar]
  72. Morris EJ, Dyson NJ. Retinoblastoma protein partners. Adv Cancer Res. 2001;82:1–54. doi: 10.1016/s0065-230x(01)82001-7. [DOI] [PubMed] [Google Scholar]
  73. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation development proliferation and apoptosis. Genes Dev. 2001;15:267–285. doi: 10.1101/gad.864201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Myster DL, Bonnette PC, Duronio RJ. A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis. Development. 2000;127:3249–3261. doi: 10.1242/dev.127.15.3249. [DOI] [PubMed] [Google Scholar]
  75. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K. Mice lacking p27(Kip1) display increased body size multiple organ hyperplasia retinal dysplasia and pituitary tumors. Cell. 1996;85:707–720. doi: 10.1016/s0092-8674(00)81237-4. [DOI] [PubMed] [Google Scholar]
  76. Olson SK, Bishop JR, Yates JR, Oegema K, Esko JD. Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG‐1 and CPG‐2. J Cell Biol. 2006;173:985–994. doi: 10.1083/jcb.200603003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Page BD, Guedes S, Waring D, Priess JR. The C. elegans E2F‐ and DP‐related proteins are required for embryonic asymmetry and negatively regulate Ras/MAPK signaling. Mol Cell. 2001;7:451–460. doi: 10.1016/s1097-2765(01)00193-9. [DOI] [PubMed] [Google Scholar]
  78. Pepper AS, Lo TW, Killian DJ, Hall DH, Hubbard EJ. The establishment of Caenorhabditis elegans germline pattern is controlled by overlapping proximal and distal somatic gonad signals. Dev Biol. 2003a;259:336–350. doi: 10.1016/s0012-1606(03)00203-3. [DOI] [PubMed] [Google Scholar]
  79. Pepper AS, Killian DJ, Hubbard EJ. Genetic analysis of Caenorhabditis elegans glp‐1 mutants suggests receptor interaction or competition. Genetics. 2003b;163:115–132. doi: 10.1093/genetics/163.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Polager S, Kalma Y, Berkovich E, Ginsberg D. E2Fs up‐regulate expression of genes involved in DNA replication DNA repair and mitosis. Oncogene. 2002;21:437–446. doi: 10.1038/sj.onc.1205102. [DOI] [PubMed] [Google Scholar]
  81. Poulin G, Dong Y, Fraser AG, Hopper NA, Ahringer J. Chromatin regulation and sumoylation in the inhibition of Ras‐induced vulval development in Caenorhabditis elegans. Embo J. 2005;24:2613–2623. doi: 10.1038/sj.emboj.7600726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Powell AK, Yates EA, Fernig DG, Turnbull JE. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology. 2004;14:17R–30R. doi: 10.1093/glycob/cwh051. [DOI] [PubMed] [Google Scholar]
  83. Ruiz S, Segrelles C, Bravo A, Santos M, Perez P, Leis H, Jorcano JL, Paramio JM. Abnormal epidermal differentiation and impaired epithelial‐mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130. Development. 2003;130:2341–2353. doi: 10.1242/dev.00453. [DOI] [PubMed] [Google Scholar]
  84. Sage C, Huang M, Karimi K, Gutierrez G, Vollrath MA, Zhang DS, Garcia‐Anoveros J, Hinds PW, Corwin JT, Corey DP, Chen ZY. Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein. Science. 2005;307:1114–1118. doi: 10.1126/science.1106642. [DOI] [PubMed] [Google Scholar]
  85. Seydoux G, Schedl T, Greenwald I. Cell‐cell interactions prevent a potential inductive interaction between soma and germline in C. elegans. Cell. 1990;61:939–951. doi: 10.1016/0092-8674(90)90060-r. [DOI] [PubMed] [Google Scholar]
  86. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672–1677. doi: 10.1126/science.274.5293.1672. [DOI] [PubMed] [Google Scholar]
  87. Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235–246. doi: 10.1016/s0092-8674(03)01075-4. [DOI] [PubMed] [Google Scholar]
  88. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2:103–112. doi: 10.1016/s1535-6108(02)00102-2. [DOI] [PubMed] [Google Scholar]
  89. Sternberg PW. Vulval Development WormBook. The. C. elegans. Research Community, Ed. 2005 doi: 10.1895/wormbook.1.6.1. http://www.wormbook.org. [DOI] [PMC free article] [PubMed]
  90. Stiernagle T. Maintenance of C. elegans WormBook. The. C. elegans. Research Community, Ed. 2005 http://www.wormbook.org.
  91. Subramaniam K, Seydoux G. Dedifferentiation of primary spermatocytes into germ cell tumors in C. elegans lacking the pumilio‐like protein PUF‐8. Curr Biol. 2003;13:134–139. doi: 10.1016/s0960-9822(03)00005-8. [DOI] [PubMed] [Google Scholar]
  92. Sundaram M, Greenwald I. Genetic and phenotypic studies of hypomorphic lin‐12 mutants in Caenorhabditis elegans. Genetics. 1993;135:755–763. doi: 10.1093/genetics/135.3.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Suzuki A, Hemmati‐Brivanlou A. Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol Cell. 2000;5:217–229. doi: 10.1016/s1097-2765(00)80418-9. [DOI] [PubMed] [Google Scholar]
  94. Takahashi C, Contreras B, Bronson RT, Loda M, Ewen ME. Genetic interaction between Rb and K‐ras in the control of differentiation and tumor suppression. Mol Cell Biol. 2004;24:10406–10415. doi: 10.1128/MCB.24.23.10406-10415.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Tong AH, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, Chang M, Chen Y, Cheng X, Chua G, Friesen H, Goldberg DS, Haynes J, Humphries C, He G, Hussein S, Ke L, Krogan N, Li Z, Levinson JN, Lu H, Menard P, Munyana C, Parsons AB, Ryan O, Tonikian R, Roberts T, Sdicu AM, Shapiro J, Sheikh B, Suter B, Wong SL, Zhang LV, Zhu H, Burd CG, Munro S, Sander C, Rine J, Greenblatt J, Peter M, Bretscher A, Bell G, Roth FP, Brown GW, Andrews B, Bussey H, Boone C. Global mapping of the yeast genetic interaction network. Science. 2004;303:808–813. doi: 10.1126/science.1091317. [DOI] [PubMed] [Google Scholar]
  96. Voutev R, Killian DJ, Ahn JH, Hubbard EJ. Alterations in ribosome biogenesis cause specific defects in C. elegans hermaphrodite gonadogenesis. Developmental Biology. 2006 doi: 10.1016/j.ydbio.2006.06.011. In Press. [DOI] [PubMed] [Google Scholar]
  97. Wang CX, Fisk BC, Wadehra M, Su H, Braun J. Overexpression of murine fizzy‐related (fzr) increases natural killer cell‐mediated cell death and suppresses tumor growth. Blood. 2000;96:259–263. [PubMed] [Google Scholar]
  98. Wang D, Kennedy S, Conte D, Jr, Kim JK, Gabel HW, Kamath RS, Mello CC, Ruvkun G. Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants. Nature. 2005;436:593–597. doi: 10.1038/nature04010. [DOI] [PubMed] [Google Scholar]
  99. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, Depinho RA, Chin L, Elledge SJ. A genetic screen for candidate tumor suppressors identifies REST. Cell. 2005;121:837–848. doi: 10.1016/j.cell.2005.03.033. [DOI] [PubMed] [Google Scholar]
  100. Westlund B, Parry D, Clover R, Basson M, Johnson CD. Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel‐12 and hop‐1 in Notch‐pathway signaling. Proc Natl Acad Sci U S A. 1999;96:2497–2502. doi: 10.1073/pnas.96.5.2497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Wikenheiser‐Brokamp KA. Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development. 2004;131:4299–4310. doi: 10.1242/dev.01232. [DOI] [PubMed] [Google Scholar]
  102. Wikenheiser‐Brokamp KA. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci. 2006;63:767–780. doi: 10.1007/s00018-005-5487-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson ML, Leone G. Extra‐embryonic function of Rb is essential for embryonic development and viability. Nature. 2003;421:942–947. doi: 10.1038/nature01417. [DOI] [PubMed] [Google Scholar]
  104. You A, Tong JK, Grozinger CM, Schreiber SL. CoREST is an integral component of the CoREST‐human histone deacetylase complex. Proc Natl Acad Sci U S A. 2001;98:1454–1458. doi: 10.1073/pnas.98.4.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES